全髋关节置换术后远期翻修风险的终身累积评估
基于新西兰关节登记系统1999至2016年全部初次全髋关节置换数据,按年龄、性别及ASA分级计算终身翻修风险。整体十年假体生存率为93.6%,46至50岁组终身翻修风险达27.6%,随年龄增长降至90至95岁组的1.1%,高ASA分级与更高翻修风险相关。
要点
- 46至50岁初次全髋置换者终身翻修风险为27.6%,随年龄增长而降低。
- 整体十年假体生存率93.6%,最年轻组最低,最年长组达97.5%。
- 无菌性松动、感染、假体周围骨折和脱位是翻修最常见原因。
核心结论
- 终身翻修风险较固定年限假体生存率更能反映长期结局,尤其适用于年轻患者术前咨询。
- 年轻年龄组初次全髋置换后后续翻修手术的可能性显著增高。
研究设计与样本
- 登记系统与新西兰出生、死亡和婚姻登记处链接以获取完整准确数据。
- 按初次手术时年龄分层,并依据年龄、性别和美国麻醉医师协会(ASA)分级计算终身翻修风险。
主要发现
- 整体十年假体生存率为93.6%(95%CI 93.4%至93.8%)。
- 十年假体生存率在46至50岁最年轻组最低,随年龄递增至90至95岁组达97.5%。
- 终身翻修风险在46至50岁组为27.6%(95%CI 27.3%至27.8%),随年龄增长降至90至95岁组的1.1%(95%CI 0.0%至5.8%)。
- 较高ASA分级在所有年龄组均与终身翻修风险增加相关。
- 翻修全髋关节置换最常见原因为无菌性松动、感染、假体周围骨折和脱位。
关键数值与推荐
- 46至50岁组终身翻修风险27.6%(95%CI 27.3%至27.8%)。
- 90至95岁组终身翻修风险1.1%(95%CI 0.0%至5.8%)。
- 整体十年假体生存率93.6%(95%CI 93.4%至93.8%)。
临床怎么用
- 术前咨询时可向患者提供基于年龄、性别和ASA分级的终身翻修风险估计,而非仅报告固定年限生存率。
- 对年轻患者应强调其终身翻修可能性较高,以帮助合理预期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Joint registries typically use revision of an implant as an endpoint and report survival rates after a defined number of years. However, reporting lifetime risk of revision may be more meaningful, especially in younger patients. We aimed to assess lifetime risk of revision for patients in defined age groups at the time of primary surgery. METHODS: The New Zealand Joint Registry (NZJR) was used to obtain rates and causes of revision for all primary total hip arthroplasties (THAs) performed between January 1999 and December 2016. The NZJR is linked to the New Zealand Registry of Births, Deaths and Marriages to obtain complete and accurate data. Patients were stratified by age at primary surgery, and lifetime risk of revision calculated according to age, sex, and American Society of Anesthesiologists (ASA) classification. The most common causes for revision were also analyzed for each age group. RESULTS: The overall, ten-year implant survival rate was 93.6% (95% confidence interval (CI) 93.4% to 93.8%). It was lowest in the youngest age group (46 to 50 years), rising sequentially with increasing age to 97.5% in the oldest group (90 to 95 years). Lifetime risk of revision surgery was 27.6% (95% CI 27.3% to 27.8%) in those aged 46 to 50 years, decreasing with age to 1.1% (95% CI 0.0% to 5.8%) in those aged 90 to 95 years at the time of primary surgery. Higher ASA grades were associated with an increased lifetime risk of revision across all ages. The commonest causes for revision THA were aseptic loosening, infection, periprosthetic fracture, and dislocation. CONCLUSION: When counselling patients preoperatively, the lifetime risk of revision may be a more meaningful and useful measure of longer-term outcome than implant survival at defined time periods. This study highlights the considerably increased likelihood of subsequent revision surgery in younger age groups. Cite this article: Bone Joint J 2021;103-B(3):479-485.
引用
- Nugent M, Young SW, Frampton CM, et al. The lifetime risk of revision following total hip arthroplasty. Bone Joint J. 2021. PMID: 33641431. doi:10.1302/0301-620X.103B3.BJJ-2020-0562.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。